ATYR PHARMA INC (LIFE) Stock Balance Sheet
NASDAQ:LIFE - Nasdaq - US0021202025 - Common Stock - Currency: USD
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 6.81M | 22.54M | 9.98M | 2.34M | 17.00M | |||
| Marketable Securities | 77.69M | 75.62M | 56.16M | 105.58M | 14.70M | |||
| Receivables | 2.48M | 2.44M | 11.78M | 435.00K | 2.00M | |||
| Other Current Assets | 9.94M | 2.39M | 2.95M | 5.22M | 1.80M | |||
| Total Current Assets | 96.92M | 102.99M | 80.87M | 113.57M | 35.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 12.99M | 14.05M | 11.56M | 1.81M | 3.00M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 3.34M | 3.62M | 3.36M | 158.00K | 200.00K | |||
| Total Non-Current Assets | 16.34M | 17.66M | 14.91M | 1.97M | 3.20M | |||
| TOTAL ASSETS | 113.25M | 120.65M | 95.79M | 115.54M | 38.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 507.00K | 497.00K | 264.00K | N/A | 0.00 | |||
| Accrued Expenses | 10.58M | 12.39M | 10.49M | 4.98M | 4.40M | |||
| Accounts Payable | 4.89M | 3.53M | 3.11M | 1.03M | 1.40M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 15.98M | 16.42M | 13.86M | 6.01M | 5.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 1.30M | 1.43M | 1.01M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 11.69M | 12.34M | 9.63M | 398.00K | 1.40M | |||
| Total Non-Current Liabilities | 12.81M | 13.58M | 10.46M | 223.00K | 1.20M | |||
| TOTAL LIABILITIES | 28.79M | 30.00M | 24.32M | 6.24M | 7.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -483.51M | -468.02M | -417.63M | -372.30M | -338.50M | |||
| Additional Paid In Capital | 568.07M | 558.69M | 489.50M | 481.83M | 370.20M | |||
| Minority Interest | -184.00K | -188.00K | -180.00K | -175.00K | -200.00K | |||
| Common Shares | 68.00K | 63.00K | 29.00K | 28.00K | 0.00 | |||
| Other Shareholders' Equity | -158.00K | -74.00K | -433.00K | -263.00K | 0.00 | |||
| Shares Outstanding | 68.35M | 63.29M | 29.50M | 27.79M | 11.00M | |||
| Tangible Book Value per Share | 1.24 | 1.43 | 2.42 | 3.93 | 2.88 | |||
| Total Shareholders' Equity | 84.47M | 90.66M | 71.46M | 109.30M | 31.70M | |||
| TOTAL LIABILITIES AND EQUITY | 113.25M | 120.65M | 95.79M | 115.54M | 38.70M | |||
| Statistics | ||||||||
| Debt/Equity | 0.02 | 0.02 | 0.01 | N/A | N/A | |||
| Current Ratio | 6.07 | 6.27 | 5.83 | 18.89 | 6.02 | |||
| Return On Assets (ROA) | -47.62% | -41.76% | -47.33% | -29.23% | -41.91% | |||
| Return On Equity (ROE) | -63.85% | -55.58% | -63.44% | -30.89% | -51.17% | |||
All data in USD , ROIC based on taxRate of 0.21